Storage and handling
Room temperature (25 degree C/77 degree F). Avoid excessive heat. Protect from freezing.
Room temperature (25 degree C/77 degree F). Avoid excessive heat. Protect from freezing.
500 mL for use only with automated apheresis devices Each 100 mL contains Citric Acid (anhydrous), USP 0.73 g Sodium Citrate (hydrous), USP 2.20 g Dextrose (hydrous), USP 2.45 g
Not for direct intravenous infusion. Do not use unless solution is clear and no leaks detected. Single use container. Discard unused portion. Sterile, pyrogen free solution. Rx only.
Room temperature (25 degree C/77 degree F). Avoid excessive heat. Protect from freezing.
L331-01 Product code 426A Haemonetics Corporation Braintree, MA 02184 USA Lot No. Exp. Date
HAEMONETICS ANTICOAGULANT CITRATE DEXTROSE SOLUTION, USP, FORMULA A (ACDA) 500 mL Haemonetics Corporation
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ANHYDROUS CITRIC ACID | ACTIVE INGREDIENT | XF417D3PSL | 3 | |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | LX22YL083G | 3 | |
| TRISODIUM CITRATE DIHYDRATE | ACTIVE INGREDIENT | B22547B95K | 3 | |
| ANHYDROUS CITRIC ACID | ACTIVE MOIETY | XF417D3PSL | 3 | |
| ANHYDROUS DEXTROSE | ACTIVE MOIETY | 5SL0G7R0OK | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 57826-426 | 57826-426-04 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| ANHYDROUS CITRIC ACID | XF417D3PSL | ACTIB |
| TRISODIUM CITRATE DIHYDRATE | B22547B95K | ACTIM |
| DEXTROSE MONOHYDRATE | LX22YL083G | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 018ed282-b340-a82a-e063-6294a90a17ef | 2db86c06-bcbc-4b35-83f4-6d7b48985284 | 2023-07-28 | Warnings | 2db86c06-bcbc-4b35-83f4-6d7b48985284 |
Adverse event summaries are temporarily unavailable. Other product information remains available.